Read More" />

Phase III Trials ‘Hit a Home Run’ in Advanced Endometrial Cancer – Medpage Today

Phase III Trials

TAMPA, Fla. — Immunotherapy combined with standard chemotherapy significantly improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, according to results. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *